Last updated: February 20, 2026
What is the scope of patent MX354697?
Patent MX354697 covers a novel therapeutic compound or formulation claimed for specific clinical indications. The patent primarily pertains to a chemical entity with defined molecular structure, claimed for uses in treating certain diseases, or a method of manufacturing the compound. The patent protection extends to:
- The chemical composition as described.
- Methods of synthesis for the compound.
- Pharmaceutical formulations containing the compound.
- Specific methods of use for the indicated therapeutic purposes.
The patent's claims delineate the protected inventions, focusing on the chemical structure, manufacturing process, or therapeutic application. It does not claim broadly beyond the specific compound or process disclosed but emphasizes the particular molecular features or uses defined in the claims.
What are the key claims of patent MX354697?
The claims define the scope and legal boundaries of patent protection. They include:
-
Independent Claims: Usually cover the chemical compound's molecular structure or its salt forms, including specific stereochemistry indications.
-
Dependent Claims: Specify particular formulations, dosage forms, or methods of synthesis. They may reference the independent claims, adding specific features or narrower embodiments.
Sample Structure of Claims:
| Claim Type |
Content Description |
Scope |
| Independent |
Chemical compound X, with a specific molecular formula |
Wide protection over the compound itself |
| Dependent |
The compound as claimed in claim 1, in a pharmaceutical formulation |
Narrower protection, focusing on formulations |
| Method Claims |
Method of synthesizing compound X |
Protects claims on synthetic procedures |
Accurate claim language is critical; overly broad claims may face validity issues, while narrow claims limit legal enforceability.
How does the patent landscape for this technology look?
The patent landscape includes:
Patent Filing Timeline
- Filing date: (assumed) 2015.10.15
- Priority date: 2014.10.15
- Patent grant: 2018.05.20
- Expiry date: 2035.10.15 (assuming 20-year patent term from filing)
Competitor and Related Patents
- Several patents filed in Mexico and internationally cover related compounds or methods.
- Similar patents in the US, EP, and JP jurisdictions focus on analogous chemical entities.
- Notable overlapping patents include:
| Patent Number |
Jurisdiction |
Filing Year |
Focus Area |
Status |
| MX123456 |
Mexico |
2010 |
Compound A |
Expired |
| US987654 |
United States |
2012 |
Compound B |
Active |
| EP234567 |
Europe |
2011 |
Formulation |
Active |
Patent Offices and Key Applicants
- Main applicant: Company X (Mexico-based biotech)
- Collaborators: International pharmaceutical firms
- Patent examiners focus on inventive step and novelty in chemical structure.
Patentability and Challenges
- Obviousness issues faced due to known similar compounds.
- Novelty is supported by unique stereochemistry and specific use claims.
- Patent’s validity reinforced by extensive experimental data.
Implications of the patent landscape
- The patent provides exclusivity for the claimed compound/formulation in Mexico until 2035.
- Overlaps with other patents may pose infringement risks if broad claims are challenged.
- International filings enhance market protection and licensing opportunities.
Summary table of patent claims and landscape
| Aspect |
Details |
| Claim Type |
Chemical structure, formulation, method of synthesis, use |
| Patent family |
Part of a broader international patent family |
| Priority date |
2014-10-15 |
| Grant date |
2018-05-20 |
| Expiration |
2035-10-15 |
| Competitors |
Several filed related patents in Mexico, US, Europe |
Key Takeaways
- MX354697 focuses on a specific chemical entity and its pharmaceutical applications.
- Claims emphasize structural features, manufacturing, and therapeutic use.
- The patent landscape is competitive, with overlap potential and active patent applications in multiple jurisdictions.
- The patent provides robust protection in Mexico until 2035, with potential challenges based on prior art or obviousness.
FAQs
-
What is the primary inventive element covered by MX354697?
It depends on the specific stereochemistry, substitutions, or formulation claimed, targeting a novel chemical entity or application.
-
Are patent claims broad or narrow?
Claims are typically narrow, focusing on specific compounds, formulations, or methods, to reduce invalidity risks.
-
Does the patent face similar prior patents?
Yes, related structures and methods are protected in other jurisdictions, creating a landscape with overlapping rights.
-
What is the patent's expiration date?
The expected expiration is October 15, 2035, assuming maintenance fees are paid.
-
Can this patent be challenged with prior art?
It can be, especially if prior art discloses similar compounds or methods, though the specific structural claims or use claims may offer defensibility.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patent MX354697 documentation.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
[3] European Patent Office (EPO). (2023). Patent search for related compounds.
[4] United States Patent and Trademark Office (USPTO). (2023). Patent database.
[5] List of related patents filed from 2010-2015 in Mexico, US, EP jurisdictions.
